BioHarvest Sciences Inc. (BHST) stock
BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.23+0.01 (+0.82%)
Close on Nov 18, 2026Market cap $27.88MP/E –Yield –
BioHarvest Sciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $34.51M, up 37.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.51M | +37.0% |
| FY2024 | Dec 31, 2024 | $25.19M | +98.8% |
| FY2023 | Dec 31, 2023 | $12.67M | – |
See a number that looks wrong?